Skip to main content
AbbottLaunch

Abbott Laboratories stock: Product pipeline gains two updates

Source: Autobound Signal API · 112 signals tracked for Abbott · updated

Get Abbott's live signals in Claude or ChatGPT, or by API

AskWhat changed at Abbott this week? Use Autobound signals for abbott.com.

What happened

Abbott Laboratories introduced its Panbio COVID-19/Flu A&B self-test for Canadian families.

Source

Article excerpt

Highlighted: the sentence this signal was extracted from

Abbott Laboratories announced two product developments on Tuesday, November 10, spanning consumer diagnostics and cardiac devices. The updates add regulatory and product milestones as investors assess the healthcare group's pipeline. Abbott introduced a new Panbio COVID-19/Flu A&B self-test for Canadian families during the respiratory illness season. The product is positioned to support at-home testing for both COVID-19 and influenza A and B. The company also announced FDA approval and CE marking for an implantable cardioverter-defibrillator lead designed to work with the heart's natural electrical system. The milestone strengthens Abbott's presence in cardiac rhythm management, where product approvals can shape the pace of portfolio expansion. The announcements were listed in Abbott's MediaRoom on November 10. The self-test addresses seasonal respiratory diagnostics, while the cardiac lead targets a more specialized medical-device market. Together, the releases show Abbott advancing products with different regulatory and commercial profiles rather than relying on a single pipeline catalyst. Abbott Laboratories stock traded at 98.48 euros on Lang & Schwarz at 10:27 CET on Saturday, November 14, 2026. US healthcare shares remain sensitive to regulatory decisions and product launches. Current market reports are available through Current market reports. More news and analyses...

Keep reading with a free account

The rest of this article, and every signal for Abbott, is in your free account.

Extracted by Autobound

From the Signal API record
Event
Launch

What this signalsA launch often needs new go-to-market and support spend.

Product
Panbio COVID-19/Flu A&B self-test
Takes effect
Nov 10, 2026
Location
Canada

The full record

From the Signal API record

Topics and mentions

Product tags

  • medical

Extraction

Confidence
95%
Detected
Nov 14, 2026
signal_type
news
signal_subtype
launches

Use this data

Get every launch signal for Abbott and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Abbott this week?”

  2. Send it to your own tools

    The Signal API returns launch signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full news record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/9bc25286-9b23-f615-86ae-2611070cc7aa returns this record as JSON. POST /v1/companies/enrich returns every signal for abbott.com.

{
  "signal_id": "9bc25286-9b23-f615-86ae-2611070cc7aa",
  "signal_type": "news",
  "signal_subtype": "launches",
  "detected_at": "2026-11-14T09:30:00+00:00",
  "company": {
    "name": "Abbott",
    "domain": "abbott.com"
  },
  "data": {
    "url": "https://www.ad-hoc-news.de/boerse/news/corporate-news/abbott-laboratories-stock-product-pipeline-gains-two-updates/70509914",
    "title": "Abbott Laboratories stock: Product pipeline gains two updates - ad-hoc-news.de",
    "excerpt": "Abbott Laboratories announced two product developments on Tuesday, November 10, spanning consumer diagnostics and cardiac devices. The updates add regulatory and product milestones as investors assess the healthcare group's pipeline. Abbott introduced a new Panbio COVID-19/Flu A&B self-test for Canadian families during the respiratory illness season. The product is positioned to support at-home testing for both COVID-19 and influenza A and B. The company also announced FDA approval and CE marking for an implantable cardioverter-defibrillator lead designed to work with the heart's natural electrical system. The milestone strengthens Abbott's presence in cardiac rhythm management, where product approvals can shape the pace of portfolio expansion. The announcements were listed in Abbott's MediaRoom on November 10. The self-test addresses seasonal respiratory diagnostics, while the cardiac lead targets a more specialized medical-device market. Together, the releases show Abbott advancing products with different regulatory and commercial profiles rather than relying on a single pipeline catalyst. Abbott Laboratories stock traded at 98.48 euros on Lang & Schwarz at 10:27 CET on Saturday, November 14, 2026. US healthcare shares remain sensitive to regulatory decisions and product launches. Current market reports are available through Current market reports . More news and analyses...",
    "product": "Panbio COVID-19/Flu A&B self-test",
    "summary": "Abbott Laboratories introduced its Panbio COVID-19/Flu A&B self-test for Canadian families.",
    "location": "Canada",
    "planning": false,
    "image_url": "https://mdb.ad-hoc-news.de/bild/bild-2700593_1200_675.webp",
    "confidence": 0.95,
    "product_data": {
      "name": "Panbio COVID-19/Flu A&B self-test",
      "full_text": "new Panbio COVID-19/Flu A&B self-test",
      "fuzzy_match": false
    },
    "product_tags": [
      "medical"
    ],
    "published_at": "2026-11-14T09:30:00Z",
    "location_data": [
      {
        "region": "Northern America",
        "country": "Canada",
        "continent": "Americas",
        "fuzzy_match": false
      }
    ],
    "effective_date": "2026-11-10",
    "article_sentence": "Abbott introduced a new Panbio COVID-19/Flu A&B self-test for Canadian families during the respiratory illness season."
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.